Literature DB >> 10707008

The natural history and prognostic factors in patients with cirrhosis and gastric fundal varices without prior bleeding.

.   

Abstract

Objectives and methods: The prognostic factors have not yet been fully evaluated in patients with cirrhosis and gastric fundal varices (FV). We investigated the natural history of 145 patients with cirrhosis and FV with no history of bleeding. Various possible prognostic factors, which include clinical, biochemical, and endoscopical variables, were analyzed using Cox's proportional hazard model.
Results: Among the 145 patients with cirrhosis and FV, there were 76 patients in class A, 45 in class B and 24 class C according to Child's classification. Sixty-five patients had concomitant hepatocellular carcinoma at the time of enrollment. Seventy deaths and 34 episodes of the hemorrhage from FV occurred during the mean follow-up period of 26.4 months. The cumulative survival rates at 1, 3, and 5 years were 75, 53 and 34%, respectively. The cause of death was related to gastrointestinal hemorrhage in 18 patients (15 deaths were related to FV hemorrhage), hepatic failure in 22, hepatocellular carcinoma in 22, and other causes in eight patients. In patients with small-, medium-, and large-sized FV, the deaths related to FV hemorrhage were 4, 21 and 54%, respectively. Overall, the death related to FV hemorrhage was 21%. A multiple regression analysis using Cox's model showed hemorrhage from FV, the presence of hepatocellular carcinoma and poor Child's status were all highly significant prognostic factors.
Conclusion: The natural history of the patients with cirrhosis and FV was adversely modified by the hemorrhage from FV, concomitant hepatocellular carcinoma and poor hepatic functional reserve. Since the number of deaths related to FV hemorrhage was great in patients with large-sized FV, it is important to identify high-risk large FV and its prophylactic obliteration. Further studies are needed to elucidate the efficacy of prophylactic obliteration of large-sized FV.

Entities:  

Year:  2000        PMID: 10707008     DOI: 10.1016/s1386-6346(99)00072-8

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  5 in total

1.  Balloon occluded retrograde transvenous obliteration: a feasible alternative to transjugular intrahepatic portosystemic stent shunt.

Authors:  A Matsumoto; H Yamauchi; H Inokuchi
Journal:  Gut       Date:  2003-04       Impact factor: 23.059

2.  Customization of laparoscopic gastric devascularization and splenectomy for gastric varices based on CT vascular anatomy.

Authors:  Hirofumi Kawanaka; Tomohiko Akahoshi; Yoshihiro Nagao; Nao Kinjo; Daisuke Yoshida; Yoshihiro Matsumoto; Norifumi Harimoto; Shinji Itoh; Tomoharu Yoshizumi; Yoshihiko Maehara
Journal:  Surg Endosc       Date:  2017-06-21       Impact factor: 4.584

3.  Short- and long-term clinical outcome after balloon-occluded retrograde transvenous obliteration: is pretreatment portal flow direction a predictive factor?

Authors:  Hidehiro Kamezaki; Hitoshi Maruyama; Taro Shimada; Masanori Takahashi; Hidehiro Okugawa; Osamu Yokosuka
Journal:  Hepatol Int       Date:  2012-05-19       Impact factor: 6.047

4.  Long-term results of fundectomy and periesophagogastric devascularization in patients with gastric fundal variceal bleeding.

Authors:  Joo-Ho Lee; Ho-Seong Han; Hyun-Ah Kim; Min-Young Koo
Journal:  World J Surg       Date:  2009-10       Impact factor: 3.352

5.  Left Gastric Vein Width Is an Important Risk Factor for Exacerbation of Esophageal Varices Post Balloon-Occluded Retrograde Transvenous Obliteration for Gastric Varices in Cirrhotic Patients.

Authors:  Taku Mizutani; Kazushige Nirei; Tatsuo Kanda; Masayuki Honda; Tomotaka Ishii; Shuhei Arima; Yoichiro Yamana; Naoki Matsumoto; Shunichi Matsuoka; Mitsuhiko Moriyama
Journal:  Medicina (Kaunas)       Date:  2022-01-28       Impact factor: 2.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.